Navigation Links
SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor
Date:11/20/2008

DUBLIN, Calif., Nov. 20 /PRNewswire-FirstCall/ -- SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that it has received clearance to initiate clinical trials with SGI-1776, an inhibitor of Pim kinases. The clearance of its Original Investigational New Drug Application ("IND") triggers a $5.2 million milestone payment to the former stockholders of Montigen Pharmaceuticals, Inc. The milestone payment will consist of $2.8 million in cash payments and the issuance of approximately $2.4 million in equity, representing approximately 1.5 million shares of SuperGen common stock.

SuperGen will initiate a Phase I clinical trial to evaluate the safety, tolerability and pharmacokinetic profile of SGI-1776, a novel, orally administered, small molecule anticancer compound. The first in human clinical trial program will enroll patients with solid tumors with specific emphasis on hormone refractory prostate cancer and refractory non-Hodgkin's lymphomas. These solid tumor types have been reported to overexpress the Pim kinase family of proteins at a high frequency. Overexpression of Pim-1 kinase has been shown to be a marker of poor prognosis in these tumors. A second Phase I/II study is being planned in patients with refractory leukemias in which Pim kinases are also overexpressed, and correlated with poor prognosis and drug resistance.

"We are pleased to acknowledge FDA's clearance of our IND application to enter what we believe is the world's first investigational product targeted to inhibit PIM kinases into Phase I clinical trials," said Dr. James Manuso, SuperGen's President and Chief Executive Officer. "The clearance of the SGI-1776 IND application represents a validation of our Company's CLIMB(TM) technology platform and its ability to
'/>"/>

SOURCE SuperGen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. SuperGen Reports 2008 Third Quarter Financial Results
2. SuperGen to Announce 2008 Third Quarter Financial Results November 4, 2008
3. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
4. SuperGen to Present Data at EORTC-NCI-AACR
5. SuperGen to Present at Merriman 5th Annual Investor Summit on September 15, 2008
6. SuperGen Reports 2008 Second Quarter Financial Results
7. SuperGen to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 29, 2008
8. SuperGen Reports 2008 First Quarter Financial Results
9. SuperGen to Webcast 3rd Annual Analyst Day on April 29, 2008
10. SuperGen to Announce 2008 First Quarter Financial Results April 28, 2008
11. SuperGen Reports 2007 Fourth Quarter and Annual Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" ... announced next steps for its Oral Amphotericin B ... its in vitro work involving samples ... now plans to complete pre clinical studies and ... Phase 1A clinical trial, utilizing approximately $700,000 of ...
(Date:10/22/2014)... DUBLIN , Oct. 22, 2014 ... "Organic Electronics Market by Material, by Application, Geography ... report to their offering. Organic electronics, ... a branch of material science which deals with small ... as organic because small molecules and polymers are carbon ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market by product ... Table-top Counters) by End-user (Inpatient Pharmacy Automation, Outpatient ... 2019” analyzes and studies the major market drivers, ... and the Rest of the World (RoW). , ... through 300 pages and in-depth TOC on "Pharmacy ...
(Date:10/20/2014)... 2014 Convey Computer , the ... from Iowa State University won first place in the ... Convey HC-2ex, the team’s solution achieved the highest overall ... the second place finisher. , Experts from all segments ... month long challenge, using a variety of design tools, ...
Breaking Biology Technology:iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3
... be sitting in piles of cash right now. But ... isnt, hell take the latest version of WorkWises manufacturing ... is a provider of enterprise-wide solutions that help manufacturers ... assets. The company recently announced that more than 100 ...
... Both might be counter-intuitive for Wisconsin technology professionals and ... the success of high-tech industry in Wisconsin, according to ... of San Jose-based Cisco Systems , described his ... successful technology clusters at the Wisconsin Economic Summit ...
... Wisconsins secretary of the Department of Commerce, shares ... development in Wisconsin. , ,This feature is part is ... are appearing on the Wisconsin Technology Network (WTN). Titled, ... discussion and debate that will help to illustrate some ...
Cached Biology Technology:WorkWise Helps Manufacturers Squeeze Bottom Line 2Ciscos John Morgridge Speaks on How Wisconsin can Develop Successful Technology Clusters 2Ciscos John Morgridge Speaks on How Wisconsin can Develop Successful Technology Clusters 3Grow Wisconsin resources for technology development 2Grow Wisconsin resources for technology development 3
(Date:10/22/2014)... 20, 2014  Leading identity analyst firm Acuity Market ... the world,s population will have a chip-based National eID ... . Asia , with its ... for more than 60% of all National eID cards ... -- "The Global National eID Industry Report: ...
(Date:10/18/2014)... patients referred for evaluation of suspected genetic conditions, ... 25 percent, including detection of a number of ... disease, according to a study appearing in ... coincide with the American Society of Human Genetics ... or coding regions of thousands of genes simultaneously ...
(Date:10/17/2014)... Copenhagen have shown for the first time how bacteria ... patients, giving them the opportunity to get tremendous insights ... The study also discovered the bacterial growth in chronic ... or slowed down by the immune cells. The researchers ... helped "suffocate" the bacteria, forcing the bacteria to switch ...
Breaking Biology News(10 mins):Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Whole-exome sequencing shows potential as diagnostic tool 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2
... the mechanisms that underlie a pathological increase in the size ... the October 24th issue of the journal Molecular Cell ... managing this extremely common cardiac ailment that often leads to ... heart attacks can lead to a abnormal thickening of the ...
... four times more prevalent in the atmosphere than previously ... Institution of Oceanography at UC San Diego. ... geochemistry professor Ray Weiss made the first atmospheric measurements ... more effective at warming the atmosphere than an equal ...
... antioxidant in green tea may prevent or delay the ... researchers say. Researchers were testing EGCG, green tea,s ... diabetes and primary Sjogren,s syndrome, which damages moisture-producing glands, ... focused on Sjogren,s syndrome, so learning that EGCG also ...
Cached Biology News:Research uncovers new steps on pathway to enlarged heart 2Potent greenhouse gas more prevalent in atmosphere than previously assumed 2Potent greenhouse gas more prevalent in atmosphere than previously assumed 3Green tea may delay onset of type 1 diabetes 2Green tea may delay onset of type 1 diabetes 3
... Tracker Intracellular Localization Kit provides a straight ... siRNA, of your design, in an efficient ... experiments. Subcellular localization and functional inhibition of ... introduction of the labeled siRNA into mammalian ...
... The Label IT siRNA Tracker Intracellular Localization ... directly label and deliver siRNA, of your ... for in vitro tracking experiments. Subcellular localization ... can be monitored following introduction of the ...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z71,344-9) ... assistance. ID clarifier: box holds ...
... extracellular matrix (ECM) is an important step ... invasion by adhering to and spreading along ... such as MMP collagenases, dissolve tiny holes ... the blood vessels to allow cancer cells ...
Biology Products: